PT1284993E - Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas - Google Patents

Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas Download PDF

Info

Publication number
PT1284993E
PT1284993E PT01945261T PT01945261T PT1284993E PT 1284993 E PT1284993 E PT 1284993E PT 01945261 T PT01945261 T PT 01945261T PT 01945261 T PT01945261 T PT 01945261T PT 1284993 E PT1284993 E PT 1284993E
Authority
PT
Portugal
Prior art keywords
bordetella
pertactin
bronchiseptica
repeated regions
pertussis
Prior art date
Application number
PT01945261T
Other languages
English (en)
Portuguese (pt)
Inventor
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of PT1284993E publication Critical patent/PT1284993E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT01945261T 2000-05-25 2001-05-23 Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas PT1284993E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25

Publications (1)

Publication Number Publication Date
PT1284993E true PT1284993E (pt) 2008-06-11

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01945261T PT1284993E (pt) 2000-05-25 2001-05-23 Polipéptidos contendo polimorfismos das regiões repetidas de pertactina em bordetella pertussis, bordetella parapertussis e bordetella bronchiseptica, sua utilização em diagnóstico e em composições imunogénicas

Country Status (11)

Country Link
US (3) US7070779B2 (enExample)
EP (1) EP1284993B1 (enExample)
JP (1) JP2003533990A (enExample)
AT (1) ATE393166T1 (enExample)
AU (1) AU2001267527A1 (enExample)
CY (1) CY1110430T1 (enExample)
DE (1) DE60133734T2 (enExample)
DK (1) DK1284993T3 (enExample)
ES (1) ES2303833T3 (enExample)
PT (1) PT1284993E (enExample)
WO (1) WO2001090143A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
AU2001267527A1 (en) 2000-05-25 2001-12-03 Institut Pasteur Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
US8465754B2 (en) 2007-05-28 2013-06-18 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Bordetella parapertussis whole-cell vaccine composition
CU23679A1 (es) * 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
EP2430040A1 (en) * 2009-05-11 2012-03-21 Novartis AG Antigen purification process for pertactin antigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
US20130302369A1 (en) * 2011-02-04 2013-11-14 Omar Yousif Abdelmagid Immunogenic Bordetella Bronchiseptica Compositions
AU2012213034B2 (en) * 2011-02-04 2017-06-29 Zoetis Services Llc Compositions for canine respiratory disease complex
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
AU2001267527A1 (en) 2000-05-25 2001-12-03 Institut Pasteur Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Also Published As

Publication number Publication date
US20040166116A9 (en) 2004-08-26
DE60133734T2 (de) 2009-05-14
AU2001267527A1 (en) 2001-12-03
DK1284993T3 (da) 2008-07-28
ATE393166T1 (de) 2008-05-15
US7070779B2 (en) 2006-07-04
WO2001090143A3 (en) 2002-09-26
ES2303833T3 (es) 2008-09-01
US20030180307A1 (en) 2003-09-25
US20060008474A1 (en) 2006-01-12
EP1284993B1 (en) 2008-04-23
CY1110430T1 (el) 2012-05-23
JP2003533990A (ja) 2003-11-18
US20020192237A1 (en) 2002-12-19
EP1284993A2 (en) 2003-02-26
US6964767B2 (en) 2005-11-15
DE60133734D1 (de) 2008-06-05
WO2001090143A2 (en) 2001-11-29
US7314910B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
CY1110430T1 (el) Πολυπεπτιδια περιεχοντα πολυμορφισμους των επαναλαμβανομενων περιοχων της περτακτινης σε bordetella pertussis, bordetella paraperussis kai bordetella bronchiseptica. χρηση αυτων σε διαγνωστικες και ανοσογονες συνθεσεις
MXPA02010826A (es) Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
GEP20094675B (en) Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain
TR200003011T2 (tr) Yeni dihidropirimidinler.
BR0108058A (pt) Corpo maciço
WO2005046371A3 (en) Personal protection system and method for using a personal protection system
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
WO2002094190A3 (en) Heterologous protection induced by immunization with invaplex vaccine
MY136386A (en) New combination of a betablocker and a cholesterol-lowering agent
AU6720601A (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
WO2002022150A3 (de) Arzneimittel enthaltend aktiviertes antithrombin iii
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
GR3006840T3 (enExample)
MXPA02012015A (es) Ligandos de receptores para integrinas.
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
DK0863981T3 (da) Detektering, forebyggelse og behandling af papillomatous digital dermatitis
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
ES2185605T3 (es) 2,3-dihidro-1h-5,9-dioxaciclohepta (f) inden-7-onas 1,2-sustituidas y benzo (b) (1,4)dioxepin-3 onas 7-sustituidas.
PL353952A1 (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
EP2116257A3 (en) Parenteral vaccine formulations and uses thereof
IL159493A0 (en) Pharmaceutical formulation containing an ltb4 antagonist
FR2838962B1 (fr) Composition cosmetique comprenant un extrait de lentilles d'eau riche en apiose, procedes de traitement et utilisations
DK0485463T3 (da) Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
EP1591123A4 (en) USE OF NARINGENINE, NARINGIN AND THEIR SALTS AS EXPERTS IN THE TREATMENT OF COUGH AND COMPOSITIONS THEREOF